176 related articles for article (PubMed ID: 30533197)
1. Glutathione/pH-responsive nanosponges enhance strigolactone delivery to prostate cancer cells.
Argenziano M; Lombardi C; Ferrara B; Trotta F; Caldera F; Blangetti M; Koltai H; Kapulnik Y; Yarden R; Gigliotti L; Dianzani U; Dianzani C; Prandi C; Cavalli R
Oncotarget; 2018 Nov; 9(88):35813-35829. PubMed ID: 30533197
[TBL] [Abstract][Full Text] [Related]
2. Strigolactones-a novel class of phytohormones as anti-cancer agents.
Hasan MN; Razvi SSI; Kuerban A; Balamash KS; Al-Bishri WM; Abulnaja KO; Choudhry H; Khan JA; Moselhy SS; M Z; Kumosani TA; Al-Malki AL; Alhosin M; Asami T
J Pestic Sci; 2018 Aug; 43(3):168-172. PubMed ID: 30363122
[TBL] [Abstract][Full Text] [Related]
3. Biological Effect Evaluation of Glutathione-Responsive Cyclodextrin-Based Nanosponges: 2D and 3D Studies.
Argenziano M; Foglietta F; Canaparo R; Spagnolo R; Della Pepa C; Caldera F; Trotta F; Serpe L; Cavalli R
Molecules; 2020 Jun; 25(12):. PubMed ID: 32560204
[TBL] [Abstract][Full Text] [Related]
4. GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses.
Daga M; Ullio C; Argenziano M; Dianzani C; Cavalli R; Trotta F; Ferretti C; Zara GP; Gigliotti CL; Ciamporcero ES; Pettazzoni P; Corti D; Pizzimenti S; Barrera G
Free Radic Biol Med; 2016 Aug; 97():24-37. PubMed ID: 27184956
[TBL] [Abstract][Full Text] [Related]
5. Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver.
Daga M; de Graaf IAM; Argenziano M; Barranco ASM; Loeck M; Al-Adwi Y; Cucci MA; Caldera F; Trotta F; Barrera G; Casini A; Cavalli R; Pizzimenti S
Toxicol In Vitro; 2020 Jun; 65():104800. PubMed ID: 32084521
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin nanosponge for the GSH-mediated delivery of Resveratrol in human cancer cells.
Palminteri M; Dhakar NK; Ferraresi A; Caldera F; Vidoni C; Trotta F; Isidoro C
Nanotheranostics; 2021; 5(2):197-212. PubMed ID: 33564618
[TBL] [Abstract][Full Text] [Related]
7. Comparative Evaluation of Solubility, Cytotoxicity and Photostability Studies of Resveratrol and Oxyresveratrol Loaded Nanosponges.
Dhakar NK; Matencio A; Caldera F; Argenziano M; Cavalli R; Dianzani C; Zanetti M; López-Nicolás JM; Trotta F
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31635183
[TBL] [Abstract][Full Text] [Related]
8. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC
Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845
[TBL] [Abstract][Full Text] [Related]
9. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
[TBL] [Abstract][Full Text] [Related]
10. Glutathione detonated and pH responsive nano-clusters of Au nanorods with a high dose of DOX for treatment of multidrug resistant cancer.
Wang Y; Wang F; Liu Y; Xu S; Shen Y; Feng N; Guo S
Acta Biomater; 2018 Jul; 75():334-345. PubMed ID: 29885528
[TBL] [Abstract][Full Text] [Related]
11. Glutathione Bioresponsive Cyclodextrin Nanosponges.
Trotta F; Caldera F; Dianzani C; Argenziano M; Barrera G; Cavalli R
Chempluschem; 2016 May; 81(5):439-443. PubMed ID: 31968779
[TBL] [Abstract][Full Text] [Related]
12. A new role for glutathione in the regulation of root architecture linked to strigolactones.
Marquez-Garcia B; Njo M; Beeckman T; Goormachtig S; Foyer CH
Plant Cell Environ; 2014 Feb; 37(2):488-98. PubMed ID: 23906110
[TBL] [Abstract][Full Text] [Related]
13. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
Hasan MN; Choudhry H; Razvi SS; Moselhy SS; Kumosani TA; Zamzami MA; Omran Z; Halwani MA; Al-Babili S; Abualnaja KO; Al-Malki AL; Alhosin M; Asami T
Bioorg Med Chem Lett; 2018 Apr; 28(6):1077-1083. PubMed ID: 29456109
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Characterization of Carboxymethyl Chitosan Nanosponges with Cyclodextrin Blends for Drug Solubility Improvement.
Rizvi SSB; Akhtar N; Minhas MU; Mahmood A; Khan KU
Gels; 2022 Jan; 8(1):. PubMed ID: 35049590
[TBL] [Abstract][Full Text] [Related]
16. Acetaldehyde-modified-cystine functionalized Zr-MOFs for pH/GSH dual-responsive drug delivery and selective visualization of GSH in living cells.
Lin C; He H; Zhang Y; Xu M; Tian F; Li L; Wang Y
RSC Adv; 2020 Jan; 10(6):3084-3091. PubMed ID: 35497751
[TBL] [Abstract][Full Text] [Related]
17. Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells.
Pollock CB; McDonough S; Wang VS; Lee H; Ringer L; Li X; Prandi C; Lee RJ; Feldman AS; Koltai H; Kapulnik Y; Rodriguez OC; Schlegel R; Albanese C; Yarden RI
Oncotarget; 2014 Mar; 5(6):1683-98. PubMed ID: 24742967
[TBL] [Abstract][Full Text] [Related]
18. A pH-Responsive System Based on Fluorescence Enhanced Gold Nanoparticles for Renal Targeting Drug Delivery and Fibrosis Therapy.
Lai X; Geng X; Tan L; Hu J; Wang S
Int J Nanomedicine; 2020; 15():5613-5627. PubMed ID: 32884257
[TBL] [Abstract][Full Text] [Related]
19. Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes.
Li X; Yang W; Zou Y; Meng F; Deng C; Zhong Z
J Control Release; 2015 Dec; 220(Pt B):704-14. PubMed ID: 26348387
[TBL] [Abstract][Full Text] [Related]
20. Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model.
Mayzlish-Gati E; Laufer D; Grivas CF; Shaknof J; Sananes A; Bier A; Ben-Harosh S; Belausov E; Johnson MD; Artuso E; Levi O; Genin O; Prandi C; Khalaila I; Pines M; Yarden RI; Kapulnik Y; Koltai H
Cancer Biol Ther; 2015; 16(11):1682-8. PubMed ID: 26192476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
